MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$85,600K
Free Cash flow
$80,800K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net income
    • Borrowings under revolving credi...
    • Depreciation
    • Others
Negative Cash Flow Breakdown
    • Shares purchased under share rep...
    • Changes in assets and liabilitie...
    • Repayments under revolving credi...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
154,000
138,800
132,100
140,000
Depreciation
45,700
44,600
46,400
42,300
Amortization
500
600
600
700
Stock-based compensation
10,900
6,600
6,700
8,400
Non-cash restructuring charges
1,000
900
5,400
-
Pension settlement charges
-
-
0
-
Non-cash restructuring charges
-
-
-
900
Loss on disposal of plant
-
-
0
-
Asset impairments
3,900
300
7,300
300
Deferred income taxes
-
-
-13,700
-
Pension and other retirement plans, net
-
-
600
-
Equity in undistributed earnings of affiliates, net of dividends
-
-
10,500
-
Other non-cash items, net
6,000
-1,000
3,000
-2,500
Decrease (increase) in accounts receivable
-
-
-6,900
-
(increase) decrease in inventories
-
-
62,800
-
Decrease (increase) in other current assets
-
-
-9,700
-
Increase in accounts payable
-
-
17,900
-
Changes in other assets and liabilities
-
-
-108,100
-
Changes in assets and liabilities
86,000
101,000
-
-2,100
Net cash provided by operating activities
124,000
89,900
251,100
197,200
Capital expenditures
43,200
42,700
76,100
63,300
Other, net
-
-
0
0
Net cash used in investing activities
-43,200
-42,700
-76,100
-63,300
Borrowings of long-term debt
-
-
0
0
Borrowings under revolving credit agreements
50,000
-
-
-
Repayments of long-term debt
-
-
0
0
Repayments under revolving credit agreements
50,000
-
-
-
Principal repayments on finance leases
400
300
300
300
Excise tax payments
800
-
0
0
Dividend payments
15,700
15,800
15,800
15,100
Proceeds from stock-based compensation awards
6,900
5,500
3,100
2,200
Employee stock purchase plan contributions
1,900
2,000
1,500
1,800
Shares purchased under share repurchase programs
156,700
297,600
0
0
Shares repurchased for employee tax withholdings
0
2,500
200
100
Net cash used in financing activities
-164,800
-308,700
-11,700
-11,500
Effect of exchange rates on cash
-1,600
-8,400
-500
-3,600
Net (decrease) increase in cash and cash equivalents
-85,600
-269,900
162,800
118,800
Cash, including cash equivalents at beginning of period
521,400
791,300
404,200
404,200
Cash, including cash equivalents at end of period
435,800
521,400
791,300
628,500
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income$154,000K (16.84%↑ Y/Y)Depreciation$45,700K (12.01%↑ Y/Y)Stock-based compensation$10,900K (47.30%↑ Y/Y)Asset impairments$3,900K (2.63%↑ Y/Y)Non-cash restructuringcharges$1,000K (25.00%↑ Y/Y)Amortization$500K (-16.67%↓ Y/Y)Net cash provided byoperating activities$124,000K (-29.98%↓ Y/Y)Canceled cashflow$92,000K Net (decrease)increase in cash and cash...-$85,600K (-181.14%↓ Y/Y)Canceled cashflow$124,000K Borrowings under revolvingcredit agreements$50,000K Proceeds fromstock-based compensation...$6,900K (97.14%↑ Y/Y)Employee stock purchaseplan contributions$1,900K (11.76%↑ Y/Y)Changes in assets andliabilities$86,000K (1997.56%↑ Y/Y)Other non-cash items,net$6,000K (50.00%↑ Y/Y)Net cash used infinancing activities-$164,800K (-1006.04%↓ Y/Y)Canceled cashflow$58,800K Net cash used ininvesting activities-$43,200K (42.55%↑ Y/Y)Effect of exchangerates on cash-$1,600K (-108.65%↓ Y/Y)Shares purchased undershare repurchase...$156,700K (31240.00%↑ Y/Y)Repayments under revolvingcredit agreements$50,000K Dividend payments$15,700K (3.97%↑ Y/Y)Excise tax payments$800K (-80.95%↓ Y/Y)Principal repayments onfinance leases$400K (33.33%↑ Y/Y)Capital expenditures$43,200K (-42.55%↓ Y/Y)
West_Pharmaceutical_Services_Logo-svg

WEST PHARMACEUTICAL SERVICES INC (WST)

West_Pharmaceutical_Services_Logo-svg

WEST PHARMACEUTICAL SERVICES INC (WST)